CACI Proprietary Information CACI International Inc Q3 FY22 Earnings Conference Call April 28, 2022 CACI Proprietary Information -- 1 of 18 -- 2 | CACI Proprietary Information CACI Q3 FY22 Earnings Conference Call There are statements made herein that do not address historical facts and, therefore, could be interpreted to be forward- looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject to risk factors that could cause actual results to be materially different from anticipated results. These risk factors include, but are not limited to, the following: our reliance on U.S. government contracts, which includes general risk around the government contract procurement process (such as bid protest, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; significant delays or reductions in appropriations for our programs and broader changes in U.S. government funding and spending patterns; legislation that amends or changes discretionary spending levels or budget priorities, such as for homeland security or to address global pandemics like COVID-19; legal, regulatory, and political change from successive presidential administrations that could result in economic uncertainty; changes in U.S. federal agencies, current agreements with other nations, foreign events, or any other events which may affect the global economy, including the impact of global pandemics like COVID-19; the results of government audits and reviews conducted by the Defense Contract Audit Agency, the Defense Contract Management Agency, or other governmental entities with cognizant oversight; competitive factors such as pricing pressures and/or competition to hire and retain employees (particularly those with security clearances); failure to achieve contract awards in connection with re-competes for present business and/or competition for new business; regional and national economic conditions in the United States and globally, including but not limited to: terrorist activities or war, changes in interest rates, currency fluctuations, significant fluctuations in the equity markets, and market speculation regarding our continued independence; our ability to meet contractual performance obligations, including technologically complex obligations dependent on factors not wholly within our control; limited access to certain facilities required for us to perform our work, including during a global pandemic like COVID-19; changes in tax law, the interpretation of associated rules and regulations, or any other events impacting our effective tax rate; changes in technology; the potential impact of the announcement or consummation of a proposed transaction and our ability to successfully integrate the operations of our recent and any future acquisitions; our ability to achieve the objectives of near term or long-term business plans; the effects of health epidemics, pandemics and similar outbreaks may have material adverse effects on our business, financial position, results of operations and/or cash flows; and other risks described in our Securities and Exchange Commission filings. Forward-looking Statements -- 2 of 18 -- 3 | CACI Proprietary Information CACI Q3 FY22 Earnings Conference Call On Today’s Call John Mengucci President and Chief Executive Officer Thomas Mutryn Chief Financial Officer -- 3 of 18 -- 4 | CACI Proprietary Information CACI Q3 FY22 Earnings Conference Call Revenue +2% as reported, down ~2% organic Technology revenue +10% Adjusted EBITDA Margin 10.2%1 Robust free cash flow of $297 million1 Solid contract awards of $1.2 billion, including $568 million of classified work Trailing twelve months (TTM) book-to-bill 1.5x Results continue to reflect near-term headwinds, particularly funding delays Q3 FY22 Financial Highlights 1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures. -- 4 of 18 -- 5 | CACI Proprietary Information CACI Q3 FY22 Earnings Conference Call Headwinds discussed in Q2 continue Slowing pace of task orders, given acquisition resource challenges Supply chain challenges Delayed funding Restricted customer and facility access due to COVID Pace of funding in Q3 much slower than expected Q3 funding orders down over $300 million or 20% year-over-year Approved budget/funding will have limited benefit to FY22 given timing of FY end Modestly reducing FY22 guidance Short-Term Headwinds Continue… -- 5 of 18 -- 6 | CACI Proprietary Information CACI Q3 FY22 Earnings Conference Call Headwinds are short-term and not impacting customer demand or long-term growth opportunities Large and growing addressable market, very constructive budget environment GFY22 and GFY23 budgets indicate increased spending in areas of CACI focus Defense Intelligence Community (IC) Homeland Security (DHS is CACI’s largest non-DoD customer) IT Modernization, including application and network modernization Space domain, including photonics and space situational awareness Other areas of potential spending increases include R&D (e.g., DARPA), cyber, artificial intelligence (AI), the electromagnetic spectrum, and C-UAS …But Longer-Term Market Trends Very Positive -- 6 of 18 -- 7 | CACI Proprietary Information CACI Q3 FY22 Earnings Conference Call IT Modernization Network modernization includes Commercial Solutions for Classified, or CSfC SteelBox® – subscription-based, software as a service (SaaS) application for secure communications (voice and messaging), currently deployed in the IC ID Technologies acquisition expands portfolio of CSfC end-point offerings Space Photonics – recent successful demonstration by SA Photonics of optical link and data transfer between satellites in low earth orbit (LEO), in partnership with DARPA and SDA CACI preparing two software-defined mission payloads for launch into low earth orbit – demonstrating Assured Positioning Navigation and Timing (APNT) and Tactical Intelligence, Surveillance, and Reconnaissance (TacISR) technology Investing Ahead of Need -- 7 of 18 -- 8 | CACI Proprietary Information CACI Q3 FY22 Earnings Conference Call Delivering operational excellence, healthy profitability, and strong cash flow Successfully investing ahead of need and differentiating in the marketplace Attracting and retaining talent – continued recognition as a “Top Workplace” Preliminary FY23 outlook is positive Expect healthy organic growth, profitability, and cash flow Expect funding to revert to normal levels in early FY23 Will provide formal FY23 guidance with more details in mid-August Business Performing Well -- 8 of 18 -- 9 | CACI Proprietary Information CACI Q3 FY22 Earnings Conference Call Q3 Financial Summary $4.78 $4.04 $0.00 $1.00 $2.00 $3.00 $4.00 $5.00 $6.00 Q3 FY21 Q3 FY22 Diluted EPS (GAAP) $1,552 $1,584 $1,400 $1,450 $1,500 $1,550 $1,600 Q3 FY21 Q3 FY22 Revenue (Ms) Organic revenue down ~2% Technology revenue +10% Adjusted EBITDA Margin of 10.2%1 +2% -15% 1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures. $5.28 $4.64 $0.00 $1.00 $2.00 $3.00 $4.00 $5.00 $6.00 $7.00 Q3 FY21 Q3 FY22 Adjusted Diluted EPS1 -12% -- 9 of 18 -- 10 | CACI Proprietary Information CACI Q3 FY22 Earnings Conference Call Strong Cash Flow $0 $50 $100 $150 $200 $250 $300 $350 $400 $450 $500 $550 $600 $650 $700 $750 Cash Flow1 and CapEx (millions, TTM) Cash Flow from Operations excl. MARPA Capital Expenditures (CapEx) 1 Excludes CACI’s Master Accounts Receivable Purchase Agreement (MARPA). FY20 includes CARES Act payroll tax deferral benefit of ~$41 million. FY21 includes CARES Act payroll tax deferral benefit of ~$53 million and tax payment of ~$90 million due to certain tax elections. FY22E includes estimated tax benefits of ~$230 million and repayment of payroll tax deferral of ~$47 million. See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures. 1 $0.00 $5.00 $10.00 $15.00 $20.00 $25.00 $30.00 $35.00 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22E Free Cash Flow (FCF) per Share1 FY15 to FY20 FY16 to FY21 FY17 to FY22E 5-Year CAGR 14.9% 19.2% 26.2% FY22E is based on guidance provided on April 27, 2022. Investors are reminded that actual results may differ from these estimates for reasons described in the Company’s Safe Harbor Statement and filings with the SEC. -- 10 of 18 -- 11 | CACI Proprietary Information CACI Q3 FY22 Earnings Conference Call Updating FY22 Guidance FY22 Guidance Revenue (millions) $6,200 – $6,250 Adjusted Net Income1 (millions) $415 – $425 Adjusted Diluted EPS1 $17.51 – $17.93 Free Cash Flow1 (millions) At least $720 (1) For additional information regarding non-GAAP measures, please see the related explanation and reconciliation slides at the end of this presentation. This guidance represents CACI views as of April 27, 2022. Investors are reminded that actual results may differ from these estimates for reasons described in the Company’s Safe Harbor Statement and filings with the SEC. Organic revenue growth of ~1% at the midpoint, incl. Afghanistan headwind (2%) Adj. EBITDA Margin1 of ~10.5% (incl. 10 bps impact from acquisitions) Effective tax rate of ~22% Diluted shares outstanding expected to be ~23.7 million Capital expenditures of ~$80 million -- 11 of 18 -- 12 | CACI Proprietary Information CACI Q3 FY22 Earnings Conference Call Positive Forward Indicators 98% Existing Business STRONG Performance 1% Recompetes HIGH Win Rate 1% New Business QUALITY Pipeline Solid Q3 FY22 contract awards of $1.2 billion TTM Book-to-Bill of 1.5x Backlog of $23.5 billion, +5% YoY Pipeline of submitted bids: $10 billion ~90% for new business to CACI Bids expected to be submitted in the next two quarters: $20 billion ~90% for new business to CACI -- 12 of 18 -- 13 | CACI Proprietary Information CACI Q3 FY22 Earnings Conference Call Short-term headwinds do not change long-term growth opportunities Bipartisan support continues for national security and modernization, CACI is well-aligned to key priorities Business performing well on things we can control Investing ahead of customer need driving healthy awards and growing backlog Committed to long-term growth ahead of our addressable market, margin expansion, strong cash flow, and flexible and opportunistic capital deployment to drive shareholder value Our talented, innovative, diverse employees committed to success Continuing to Execute -- 13 of 18 -- 14 | CACI Proprietary Information CACI Q3 FY22 Earnings Conference Call Adjusted net income and Adjusted diluted EPS are non-GAAP performance measures. We define Adjusted net income and Adjusted diluted EPS as GAAP net income and GAAP diluted EPS, respectively, excluding intangible amortization expense and the related tax impact as we do not consider intangible amortization expense to be indicative of our core operating performance. We believe that these performance measures provide management and investors with useful information in assessing trends in our ongoing operating performance, provide greater visibility in understanding the long-term financial performance of the Company, and allow investors to more easily compare our results to results of our peers. These non-GAAP measures should not be considered in isolation or as a substitute for performance measures prepared in accordance with GAAP. The Company views Adjusted EBITDA and Adjusted EBITDA margin, both of which are defined as non-GAAP measures, as important indicators of performance, consistent with the manner in which management measures and forecasts the Company’s performance. Adjusted EBITDA is a commonly used non-GAAP measure when comparing our results with those of other companies. We define Adjusted EBITDA as GAAP net income plus net interest expense, income taxes, depreciation and amortization expense (including depreciation within direct costs), and earnout adjustments. We consider Adjusted EBITDA to be a useful metric for management and investors to evaluate and compare the ongoing operating performance of our business on a consistent basis across reporting periods, as it eliminates the effect of non-cash items such as depreciation of tangible assets, amortization of intangible assets primarily recognized in business combinations, as well as the effect of earnout gains and losses, which we do not believe are indicative of our core operating performance. Adjusted EBITDA margin is adjusted EBITDA divided by revenue. These non-GAAP measures should not be considered in isolation or as a substitute for performance measures prepared in accordance with GAAP. The Company defines Net cash provided by operating activities excluding MARPA, a non-GAAP measure, as net cash provided by operating activities calculated in accordance with GAAP, adjusted to exclude cash flows from CACI’s Master Accounts Receivable Purchase Agreement (MARPA) for the sale of certain designated eligible U.S. government receivables up to a maximum amount of $200.0 million. Free cash flow is a non-GAAP liquidity measure and may not be comparable to similarly titled measures used by other companies. The Company defines Free cash flow as Net cash provided by operating activities excluding MARPA, less payments for capital expenditures. Free cash flow per share is computed by dividing free cash flow, as defined here, by the diluted weighted average number of common shares outstanding. The Company uses these non-GAAP measures to assess our ability to generate cash from our business operations and plan for future operating and capital actions. We believe this measure allows investors to more easily compare current period results to prior period results and to results of our peers. Free cash flow does not represent residual cash flows available for discretionary purposes and should not be used as a substitute for cash flow measures prepared in accordance with GAAP. These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP. Definitions of Non-GAAP Measures -- 14 of 18 -- 15 | CACI Proprietary Information CACI Q3 FY22 Earnings Conference Call Reconciliation of Net Income to Adjusted Net Income and Diluted EPS to Adjusted Diluted EPS (Unaudited) These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP. (in thousands, except per share data) 3/31/2022 3/31/2021 % Change 3/31/2022 3/31/2021 % Change Net income, as reported 95,417 $ 120,344 $ -20.7% 273,825 $ 320,466 $ -14.6% Intangible amortization expense 19,297 16,993 13.6% 54,944 50,605 8.6% Tax effect of intangible amortization1 (5,074) (4,468) 13.6% (14,446) (13,306) 8.6% Adjusted net income 109,640 $ 132,869 $ -17.5% 314,323 $ 357,765 $ -12.1% 3/31/2022 3/31/2021 % Change 3/31/2022 3/31/2021 % Change Diluted EPS, as reported 4.04 $ 4.78 $ -15.5% 11.56 $ 12.66 $ -8.7% Intangible amortization expense 0.82 0.68 20.6% 2.32 2.00 16.0% Tax effect of intangible amortization1 (0.22) (0.18) 22.2% (0.61) (0.52) 17.3% Adjusted diluted EPS 4.64 $ 5.28 $ -12.1% 13.27 $ 14.14 $ -6.2% (in millions, except per share data) Low End High End Net income, as reported 360 $ --- 370 $ Intangible amortization expense 74 --- 74 Tax effect of intangible amortization1 (19) --- (19) Adjusted net income 415 $ --- 425 $ Low End High End Diluted EPS, as reported 15.19 $ --- 15.61 $ Intangible amortization expense 3.12 --- 3.12 Tax effect of intangible amortization1 (0.80) --- (0.80) Adjusted diluted EPS 17.51 $ --- 17.93 $ (1) Calculation uses an assumed statutory tax rate of 26.3% on non-GAAP tax deductible adjustments. Note: Numbers may not sum due to rounding. FY22 Guidance Range FY22 Guidance Range Three Months Ended Nine Months Ended Three Months Ended Nine Months Ended -- 15 of 18 -- 16 | CACI Proprietary Information CACI Q3 FY22 Earnings Conference Call Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA) (Unaudited) These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP. (in thousands) 3/31/2022 3/31/2021 % Change 3/31/2022 3/31/2021 % Change Net income 95,417 $ 120,344 $ -20.7% 273,825 $ 320,466 $ -14.6% Plus: Income taxes 20,855 22,140 -5.8% 72,176 78,914 -8.5% Interest income and expense, net 9,084 8,954 1.5% 30,491 28,021 8.8% Depreciation and amortization expense, including amounts within direct costs 36,095 32,213 12.1% 103,924 96,266 8.0% Adjusted EBITDA 161,451 $ 183,651 $ -12.1% 480,416 $ 523,667 $ -8.3% (in thousands) 3/31/2022 3/31/2021 % Change 3/31/2022 3/31/2021 % Change Revenues, as reported 1,583,980 $ 1,551,918 $ 2.1% 4,560,656 $ 4,480,135 $ 1.8% Adjusted EBITDA 161,451 183,651 -12.1% 480,416 523,667 -8.3% Adjusted EBITDA margin 10.2% 11.8% 10.5% 11.7% Three Months Ended Nine Months Ended Three Months Ended Nine Months Ended -- 16 of 18 -- 17 | CACI Proprietary Information CACI Q3 FY22 Earnings Conference Call Reconciliation of Net Cash Provided by Operating Activities to Net Cash Provided by Operating Activities Excluding MARPA and to Free Cash Flow (Unaudited) These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP. (in thousands) 3/31/2022 3/31/2021 3/31/2022 3/31/2021 Net cash provided by operating activities 284,248 $ 118,229 $ 593,013 $ 500,516 $ Cash used in (provided by) MARPA 29,811 9,898 24,360 10,140 Net cash provided by operating activities excluding MARPA 314,059 128,127 617,373 510,656 Capital expenditures (17,110) (19,400) (38,742) (51,273) Free cash flow 296,949 $ 108,727 $ 578,631 $ 459,383 $ (in millions) FY22 Guidance Net cash provided by operating activities1 800 $ Cash used in (provided by) MARPA - Net cash provided by operating activities excluding MARPA 800 Capital expenditures (80) Free cash flow 720 $ Three Months Ended Nine Months Ended (1) Includes estimated tax benefits of $230 million related to certain tax elections, as well as payroll tax deferral repayment of approximately $47 million. -- 17 of 18 -- 18 | CACI Proprietary Information CACI Q3 FY22 Earnings Conference Call Reconciliation of Net Cash Provided by Operating Activities to Net Cash Provided by Operating Activities Excluding MARPA, to Free Cash Flow, and to Free Cash Flow per share (Unaudited) These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP. (in thousands, except per share data) 6/30/2014 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 (E) Net cash provided by operating activities 203,470 $ 226,862 $ 242,577 $ 281,250 $ 321,460 $ 555,297 $ 518,705 $ 592,215 $ 800,000 $ Cash used in (provided by) MARPA - - - - - (192,527) (7,473) 17,973 - Net cash provided by operating activities excluding MARPA1 203,470 226,862 242,577 281,250 321,460 362,770 511,232 610,188 800,000 Capital expenditures (15,279) (17,444) (20,835) (43,268) (41,594) (47,902) (72,303) (73,129) (80,000) Free cash flow 188,191 $ 209,418 $ 221,742 $ 237,982 $ 279,866 $ 314,868 $ 438,929 $ 537,059 $ 720,000 $ Diluted weighted average shares outstanding 25,155 24,388 24,802 25,069 25,255 25,395 25,485 24,992 23,700 Free cash flow per share 7.48 $ 8.59 $ 8.94 $ 9.49 $ 11.08 $ 12.40 $ 17.22 $ 21.49 $ 30.38 $ 5-Year CAGR 10.6% 14.9% 19.2% 26.2% Note: 6/30/2022 (E) reflects estimate for fiscal year 2022 based on financial guidance provided. Twelve Months Ended 1 Excludes CACI’s Master Accounts Receivable Purchase Agreement (MARPA). FY20 includes CARES Act payroll tax deferral benefit of ~$41 million. FY21 includes CARES Act payroll tax deferral benefit of ~$53 million and tax payment of ~$90 million due to certain tax elections. FY22E includes estimated tax benefits of ~$230 million and repayment of payroll tax deferral of ~$47 million. -- 18 of 18 --